DEB vs Thin-DES in DES-ISR: Long Term Outcomes (DEB Dragon Registry)

CompletedOBSERVATIONAL
Enrollment

1,369

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

March 1, 2020

Conditions
In Stent Restenosis
Interventions
DEVICE

percutaneous coronary intervention

Percutaneous coronary intervention with drug eluting balloon (DEB) vs. thin struts drug eluting stents (thin-DES) for treating in-stent restenosis (ISR)

Trial Locations (9)

15-089

Department of Invasive Cardiology, Medical University of Bialystok, Bialystok

Unknown

Cardiovascular Institute, Nicolaus Copernicus University, Bydgoszcz, Poland, Bydgoszcz

First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland, Gdansk

Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland, Krakow

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland, Warsaw

Department of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw

Centre for Heart Disease, University Hospital Wroclaw Department of Heart Disease, Wroclaw Medical University, Wroclaw

Third Department of Cardiology, Medical University of Katowice, Zabrze

40-635

Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland, Katowice

All Listed Sponsors
collaborator

Wojciech Wojakowski

UNKNOWN

lead

Medical University of Silesia

OTHER

NCT04415216 - DEB vs Thin-DES in DES-ISR: Long Term Outcomes (DEB Dragon Registry) | Biotech Hunter | Biotech Hunter